Former Tobacco Executive Takes CDC Role

Follow Drugslib on

By HealthDay Staff HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

FRIDAY, April 24, 2026 — A new hire at the U.S. Centers for Disease Control and Prevention (CDC) is drawing backlash from public health experts who worry about his influence in the industry.

Stephen Sayle, named last month as the CDC’s deputy director for legislative affairs, previously worked for Fontem Ventures, a British tobacco company subsidiary.

The company focuses on products like e-cigarettes and nicotine pouches.

In an editorial published in the journalTobacco Control, Dr. Timothy McAfee, a former head of the CDC’s Office of Smoking and Health, called the appointment “unprecedented.”

“It should be 100% clear that we don’t want former tobacco industry executives working inside the nation’s public health agencies helping influence policy adoption,” McAfee told STAT News in an email.

Others also said Sayle's employment breaks earlier promises from U.S. Health Secretary Robert F. Kennedy Jr. to “shut the revolving door” between industry and government, STAT said.

Federal officials defended the appointment.

Andrew Nixon, a spokesperson for the U.S. Department of Health and Human Services (HHS), told STAT that Sayle brings “more than 25 years of experience working at senior levels of the federal government and will be a valuable asset at the CDC to ensure effective coordination with Congress."

The appointment comes at a time when many public health advocates are more worried about the administration's tobacco policy.

Some officials pointed to actions like dropping plans to ban menthol cigarettes and taking a more favorable stance on vaping.

Kelsey Romeo-Stuppy, managing attorney at the anti-tobacco group Action on Smoking and Health, said Sayle’s hire adds to those worries.

“This is just another step further in that direction of failing to protect Americans from the harms of tobacco, and in fact going in the opposite direction," she told STAT.

Jeff Hauser of the Revolving Door Project also criticized the appointment. In an email to STAT, he warned that you "can hardly imagine a more nihilistic and disturbing message to send than turning public health policy over, in part, to someone who has dedicated much of their career to maximizing the consumption of inherently unhealthy products."

Officials said Sayle does not have any tobacco company stocks. But, according to McAfee, this new appointment is “opening a door that has been closed for decades, and letting the fox into the henhouse with open arms.”

Sources

  • STAT News, April 22, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-25 01:43

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords